Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:34 PM
Ignite Modification Date:
2025-12-24 @ 5:34 PM
NCT ID:
NCT00005668
Eligibility Criteria:
Inclusion Criteria:
You may be eligible for this study if you:
* Are 18 years of age or older.
* Have been diagnosed with aspergilloma within the last month.
* Have (or have a history of) at least one of the following:
1. positive test for Aspergillus species.
2. presence of antibodies to Aspergillus.
* Are willing to participate in the study for 2 full years.
* Are female and not pregnant.
* Are not breast-feeding.
* Agree to use barrier methods of birth control / contraception during the study and for 30 days after.
Exclusion Criteria:
You will not be eligible for this study if you:
* Have a history of allergy to triazole or imidazole drugs.
* Are unable to take oral medication.
* Are not expected to live for more than a month.
* Have had a lung biopsy indicating Aspergillus infection.
* Have had radiation therapy within the last 6 months.
* Require treatment with certain medications.
* Received amphotericin, amphotericin lipid formulation, fluconazole, or itraconazole in the two weeks prior to study entry.
* Received chemotherapy within the last 6 months.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00005668
Study Brief:
Protocol Section:
NCT00005668